Treatment options and response of IPSID
Stage of disease . | Treatment . | Overall response . |
---|---|---|
1. Early bowel wall involvement; no visible tumor | 1. Antibiotics: tetracycline, 1 g/d for 6 mo16,17,19,22 | 30%-70% CR lasting months to several years |
2. Metronidazole plus ampicillin/tetracycline62 | 43% 5-y DFS | |
3. H pylori regimen for 7 d (1 patient)63 | 5+ mo | |
4. C jejuni treatment with H pylori regimen for 5 mo (1 patient)26 | 12+ mo | |
2. Advanced disease with bowel wall tumor formation with or without mesenteric node involvement | Anthracycline-based combination chemotherapy ± tetracycline30,64,65 | 50%-60% CR lasting months to years (60%-70% DFS at 3 y) |
3. Advanced bulky tumor with mechanical complications | Corrective surgery, palliative radiation therapy, combination chemotherapy16,19,22 | Partial response, few months to less than 1 y |
Stage of disease . | Treatment . | Overall response . |
---|---|---|
1. Early bowel wall involvement; no visible tumor | 1. Antibiotics: tetracycline, 1 g/d for 6 mo16,17,19,22 | 30%-70% CR lasting months to several years |
2. Metronidazole plus ampicillin/tetracycline62 | 43% 5-y DFS | |
3. H pylori regimen for 7 d (1 patient)63 | 5+ mo | |
4. C jejuni treatment with H pylori regimen for 5 mo (1 patient)26 | 12+ mo | |
2. Advanced disease with bowel wall tumor formation with or without mesenteric node involvement | Anthracycline-based combination chemotherapy ± tetracycline30,64,65 | 50%-60% CR lasting months to years (60%-70% DFS at 3 y) |
3. Advanced bulky tumor with mechanical complications | Corrective surgery, palliative radiation therapy, combination chemotherapy16,19,22 | Partial response, few months to less than 1 y |